[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335612-105":59,"doc-detail-335612-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","yap1-overexpression-enhances-the-aerobic-glycolysis-process-via-suppression-of-egln2-in-pancreatic-ductal-adenocarcinoma","YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma","","Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive cancers, with high mortality, and its glucose metabolism reprogramming remains mechanistically unclear. This study investigates Yes-associated protein (YAP1), a Hippo pathway effector, and its role in regulating aerobic glycolysis in pancreatic cancer. YAP1 and glycolytic enzyme contributions to prognosis are evaluated using TCGA, while experiments use shRNA knockdown and Seahorse XF respirometry to assess glycolytic activity and mitochondrial respiration.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/yap1-overexpression-enhances-the-aerobic-glycolysis-process-via-suppression-of-egln2-in-pancreatic-ductal-adenocarcinoma/335612/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/yap1-overexpression-enhances-the-aerobic-glycolysis-process-via-suppression-of-egln2-in-pancreatic-ductal-adenocarcinoma/335612.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What disease and metabolic process does the study focus on?","Question",{"text":112,"@type":113},"The study focuses on pancreatic ductal adenocarcinoma (PDAC) and how aerobic glycolysis (glucose metabolism) is regulated in pancreatic cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was YAP1 tested experimentally in relation to glycolysis?",{"text":117,"@type":113},"YAP1 expression was silenced using short hairpin RNA (shRNA), and changes in glycolytic activity and mitochondrial respiration were measured with Agilent Seahorse XF Analysers.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathway does YAP1 act through according to the results?",{"text":121,"@type":113},"The results indicate that YAP1 increases aerobic glycolysis by inhibiting EGLN2 expression, which elevates HIF-1α protein level and enhances HIF-1α transcriptional activity on glycolytic target genes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335612,1790022152,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","The Journal of Gene Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nYAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma  \nPengfei Hu1 | Ruohan Dou2 | Zihao Qi3 | Guanya Liu1 | Yuantao Su1  \n1Department of General Surgery, Huadong Hospital Affiliated to Fudan University, Fudan University, Shanghai, China | 2Department of Anesthesiology, Huadong Hospital Affiliated to Fudan University, Fudan University, Shanghai, China | 3Department of General Pancreatic Surgery, Shanghai General  \nHospital, Shanghai Jiao Tong University, Shanghai, China Correspondence: Yuantao Su ([suyuantao@sina.cn](suyuantao@sina.cn))  \nReceived: 25 March 2024 | Revised: 12 October 2024 | Accepted: 1 November 2024  \nFunding: This work was supported by the Natural Science Foundation of China project (82002537) .  \nKeywords: aerobic glycolysis | EGLN2 | HIF-1α | pancreatic cancer | YAP1  \nABSTRACT  \nBackground: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases and has remarkably high mortality rates. In recent years, altered metabolism has been shown to contribute to the maintenance of pancreatic cancer malignancies. However, the molecular mechanism underlying glucose metabolism reprogramming remains elusive. The aim of this study was to elucidate the role of Yes-associated protein (YAP1), an important effector of the Hippo pathway, in the regulation of aerobic glycolysis in pancreatic cancer. Moreover, the contributions of YAP1 and its associated glycolytic enzymes to prognosis were assessed via The Cancer Genome Atlas (TCGA) dataset.  \nMethods: YAP1 expression was silenced by short hairpin RNA (shRNA), and its effects on glycolytic activity and mitochondrial respiration were analysed via Agilent Seahorse XF Analysers. The effects of YAP1 on hypoxia-inducible factor-1α (HIF-1α) and its transcriptional activity on glycolytic genes were examined via shRNA-mediated silencing of YAP1 . The underlying mechanism by which YAP1 controls the HIF-1α protein level was analysed by exploring the interaction between YAP1 and egg-layingdefective nine family (EGLN) members, which are well-established regulators of the HIF-1α protein level. Finally, the effects of YAP1, EGLN and glycolytic genes on prognosis were analysed via TCGA dataset.  \nResults: We found that silencing YAP1 expression inhibited anabolic glycolysis in pancreatic cancer cells. YAP1 was demonstrated to regulate the HIF-1α protein level, transcriptional activity and the expression of HIF-1α-targeted glycolytic genes. Indepth analysis demonstrated that EGLN2, a modulator of the HIF-1α protein level, was a direct target of YAP1 . Low EGLN2 expression was associated with a poor prognosis. By analysing TCGA dataset and performing immunohistochemical staining, we demonstrated that YAP1 expression was negatively correlated with EGLN2 expression at the mRNA level and protein levels. Conclusions: The present study demonstrated that YAP1 positively regulates aerobic glycolysis by inhibiting EGLN2 expression, which results in an increased HIF-1α protein level and transcriptional activity. YAP1 was positively regulated and significantly correlated with HIF-1α-targeted glycolytic genes, including glucose transporter type 1(GLUT1), hexokinase2 (HK2) and lactate  \n\n| Abbreviations: ECAR, extracellular acidification rate; EGLN, egg-laying-defective nine family; GLUT1, glucose transporter type 1; HDH, Huadong Hospital; HIF-1α, hypoxia-inducible factor-1α; HK2, hexokinase2; HRE, hypoxic response element; LDHA, lactate dehydrogenase A; OCR, oxygen consumption rate; ODD, oxygen-dependent degradation; OS, overall survival; PDAC, pancreatic ductal adenocarcinoma; TCGA, The Cancer Genome Atlas; YAP1, Yes-associated protein; YBE, YAP1 binding element.\u003Cbr>Pengfei Hu, Ruohan Dou and Zihao Qi contributed equally to this article. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDeri","cbCaicYrYyEKHA5n","https://ap.wps.com/l/cbCaicYrYyEKHA5n","pdf",6949571,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What disease and metabolic process does the study focus on?\",\"answer\":\"The study focuses on pancreatic ductal adenocarcinoma (PDAC) and how aerobic glycolysis (glucose metabolism) is regulated in pancreatic cancer cells.\"},{\"question\":\"How was YAP1 tested experimentally in relation to glycolysis?\",\"answer\":\"YAP1 expression was silenced using short hairpin RNA (shRNA), and changes in glycolytic activity and mitochondrial respiration were measured with Agilent Seahorse XF Analysers.\"},{\"question\":\"What molecular pathway does YAP1 act through according to the results?\",\"answer\":\"The results indicate that YAP1 increases aerobic glycolysis by inhibiting EGLN2 expression, which elevates HIF-1α protein level and enhances HIF-1α transcriptional activity on glycolytic target genes.\"}]","YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma | PDF",1790011632]